Charles River Labs downgraded at Argus on cautious biotech spending – Seeking Alpha

Charles River Labs downgraded at Argus on cautious biotech spending  Seeking AlphaBarclays sets Charles River Labs stock target with Equalweight rating By Investing.com  Investing.comDemystifying Charles River: Insights From 4 Analyst Reviews – Charles River (NYSE:CRL)  BenzingaDemystifying Charles River: Insights From 4 Analyst Reviews  Quantisnow
Read More…

Source: https://seekingalpha.com/news/4120693-charles-river-labs-downgraded-argus-cautious-biotech-spending?source=feed_sector_healthcare